FR2218879A2 - - Google Patents

Info

Publication number
FR2218879A2
FR2218879A2 FR7406232A FR7406232A FR2218879A2 FR 2218879 A2 FR2218879 A2 FR 2218879A2 FR 7406232 A FR7406232 A FR 7406232A FR 7406232 A FR7406232 A FR 7406232A FR 2218879 A2 FR2218879 A2 FR 2218879A2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7406232A
Other languages
French (fr)
Other versions
FR2218879B2 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US335211A external-priority patent/US3904597A/en
Priority claimed from US335210A external-priority patent/US3886139A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2218879A2 publication Critical patent/FR2218879A2/fr
Application granted granted Critical
Publication of FR2218879B2 publication Critical patent/FR2218879B2/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FR7406232A 1973-02-23 1974-02-22 Expired FR2218879B2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US335211A US3904597A (en) 1973-02-23 1973-02-23 Antibiotic derivatives
US335210A US3886139A (en) 1973-02-23 1973-02-23 Derivatives of kanamycin

Publications (2)

Publication Number Publication Date
FR2218879A2 true FR2218879A2 (es) 1974-09-20
FR2218879B2 FR2218879B2 (es) 1978-05-26

Family

ID=26989599

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7406232A Expired FR2218879B2 (es) 1973-02-23 1974-02-22

Country Status (9)

Country Link
JP (1) JPS553360B2 (es)
CA (1) CA1046513A (es)
CH (1) CH599243A5 (es)
DE (1) DE2408666C3 (es)
DK (1) DK140259B (es)
FR (1) FR2218879B2 (es)
GB (1) GB1467401A (es)
NL (1) NL7402456A (es)
SE (1) SE417972B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000473A1 (en) * 1977-06-24 1979-02-07 Technobiotic Ltd. Process for preparing aminoglycoside derivatives, novel derivatives obtained and pharmaceutical compositions containing such derivatives

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5512038B2 (es) * 1973-05-15 1980-03-29
US9981896B2 (en) 2016-07-01 2018-05-29 Res Usa, Llc Conversion of methane to dimethyl ether
US9938217B2 (en) 2016-07-01 2018-04-10 Res Usa, Llc Fluidized bed membrane reactor
WO2018004993A1 (en) 2016-07-01 2018-01-04 Res Usa, Llc Reduction of greenhouse gas emission

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2181797A1 (es) * 1972-03-08 1973-12-07 Bristol Myers Co

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2181797A1 (es) * 1972-03-08 1973-12-07 Bristol Myers Co

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000473A1 (en) * 1977-06-24 1979-02-07 Technobiotic Ltd. Process for preparing aminoglycoside derivatives, novel derivatives obtained and pharmaceutical compositions containing such derivatives

Also Published As

Publication number Publication date
DK140259C (es) 1979-12-10
NL7402456A (es) 1974-08-27
DE2408666B2 (de) 1978-02-16
CH599243A5 (es) 1978-05-31
DK140259B (da) 1979-07-16
SE417972B (sv) 1981-04-27
AU6587574A (en) 1975-08-21
JPS553360B2 (es) 1980-01-24
CA1046513A (en) 1979-01-16
DE2408666C3 (de) 1978-10-19
FR2218879B2 (es) 1978-05-26
JPS504043A (es) 1975-01-16
GB1467401A (en) 1977-03-16
DE2408666A1 (de) 1974-09-12

Similar Documents

Publication Publication Date Title
AU476761B2 (es)
AU474593B2 (es)
AU474511B2 (es)
AU474838B2 (es)
AU476714B2 (es)
FR2218879B2 (es)
AU472848B2 (es)
AU476696B2 (es)
AU477823B2 (es)
AR193950A1 (es)
AU471461B2 (es)
AU476873B1 (es)
AU477824B2 (es)
BG19356A1 (es)
AU479422A (es)
BG26363A3 (es)
BG23327A1 (es)
BG20465A1 (es)
BG20265A3 (es)
BG20198A1 (es)
CH559482A5 (es)
BG19070A1 (es)
AU479562A (es)
AU479539A (es)
AU479522A (es)